Antibody News and Research

RSS
An antibody is a blood protein that is produced in response to and counteracts an antigen. Antibodies are produced in response to disease and help the body fight against the particular disease. In this way, antibodies help the body develop an immunity to disease.

Further Reading

ESMO Congress 2024: Shaping the future of anticancer therapies

ESMO Congress 2024: Shaping the future of anticancer therapies

MIP Discovery closes £7M Series A financing to drive commercialization in cell and gene therapy space

MIP Discovery closes £7M Series A financing to drive commercialization in cell and gene therapy space

Novel monoclonal antibody shows promise in targeting HER2-positive breast cancer cells

Novel monoclonal antibody shows promise in targeting HER2-positive breast cancer cells

Wastewater clues could revolutionize Alzheimer's detection

Wastewater clues could revolutionize Alzheimer's detection

New study pinpoints key markers for Long COVID diagnosis

New study pinpoints key markers for Long COVID diagnosis

FDA approves omalizumab for food allergy reactions based on NIH research

FDA approves omalizumab for food allergy reactions based on NIH research

Study suggests patients with severe long COVID present with variable symptoms, do not cluster in relation to organs affected or immunological states

Study suggests patients with severe long COVID present with variable symptoms, do not cluster in relation to organs affected or immunological states

Maternal mRNA COVID-19 vaccination shields infants for six months

Maternal mRNA COVID-19 vaccination shields infants for six months

Chula researchers develop wireless hepatitis B test kit for rapid diagnosis

Chula researchers develop wireless hepatitis B test kit for rapid diagnosis

Researchers discover new mechanism of action between the nutrient adaptation of intestinal stem cells and aging

Researchers discover new mechanism of action between the nutrient adaptation of intestinal stem cells and aging

Higher prepandemic physical activity levels associated with lower odds of developing and being hospitalized for COVID-19

Higher prepandemic physical activity levels associated with lower odds of developing and being hospitalized for COVID-19

Combo of targeted and immunotherapy may boost NSCLC treatment by overcoming immune resistance and enhancing anti-tumor activity

Combo of targeted and immunotherapy may boost NSCLC treatment by overcoming immune resistance and enhancing anti-tumor activity

U of M research offers new avenue of hope in the fight against chronic HIV

U of M research offers new avenue of hope in the fight against chronic HIV

Researchers develop enhanced immunotherapy for multiple myeloma treatment

Researchers develop enhanced immunotherapy for multiple myeloma treatment

Advanced melanoma survival rates improve significantly from 2013 to 2019, Dutch study finds

Advanced melanoma survival rates improve significantly from 2013 to 2019, Dutch study finds

Study finds interleukin-24 enhances CAR-T cell therapy's effectiveness against cancer stem cells

Study finds interleukin-24 enhances CAR-T cell therapy's effectiveness against cancer stem cells

Magnesium's pivotal role in slowing aging's impact

Magnesium's pivotal role in slowing aging's impact

Combination therapy offers breakthrough in NSCLC treatment

Combination therapy offers breakthrough in NSCLC treatment

Proteomic biomarkers in blood plasma as predictors of dementia in healthy individuals

Proteomic biomarkers in blood plasma as predictors of dementia in healthy individuals

Cytokine interferon-gamma can be a disease-modifying therapeutic target in multiple system atrophy

Cytokine interferon-gamma can be a disease-modifying therapeutic target in multiple system atrophy

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.